Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1)
B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2002-11, Vol.35 (10), p.1191-1203 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1203 |
|---|---|
| container_issue | 10 |
| container_start_page | 1191 |
| container_title | Clinical infectious diseases |
| container_volume | 35 |
| creator | Cohen, Jeffrey I. Davenport, David S. Stewart, John A. Deitchman, Scott Hilliard, Julia K. Chapman, Louisa E. |
| description | B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis. |
| doi_str_mv | 10.1086/344754 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_18711839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4483293</jstor_id><oup_id>10.1086/344754</oup_id><sourcerecordid>4483293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c519t-f81616ba69196cc372ee452389062137b3b17f90516ae974981a46548fc064e03</originalsourceid><addsrcrecordid>eNp10ctu1DAUBmALUdEL8AQImUURXQR84vsSRh2mUsWlKgjNxvJ4TtSUSRzspGrfnrQZdVZd2db_6Vj6DyGvgX0EZtQnLoSW4hk5AMl1oaSF5-OdSVMIw80-Ocz5mjEAw-QLsg-lACa0PSDrCwyxabBd-76ObaZVTPRHwhts7980VtS3a3p5hcl3dw_p6W0X85CQ9pF-ob_rNGT6YYYpxK7urzDULdIFpg7zzUMGJy_JXuU3GV9tzyPya356OVsU59-_ns0-nxdBgu2LyoACtfLKglUhcF0iCllyY5kqgesVX4GuLJOgPFotrAEvlBSmCkwJZPyIvJ_mdin-GzD3rqlzwM3GtxiH7MDosQFudzCkmHPCynWpbny6c8DcfZ9u6nOEb7cTh1WD6x3bFjiC4y3wOfhNlXwb6rxzgnFeSj26d5OLQ_f0Z28mc537mB6VGDdYWj7GxRTXucfbx9inv05prqVb_Fm6n7O5Wn5bzt0F_w_h3517</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18711839</pqid></control><display><type>article</type><title>Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1)</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Cohen, Jeffrey I. ; Davenport, David S. ; Stewart, John A. ; Deitchman, Scott ; Hilliard, Julia K. ; Chapman, Louisa E.</creator><creatorcontrib>Cohen, Jeffrey I. ; Davenport, David S. ; Stewart, John A. ; Deitchman, Scott ; Hilliard, Julia K. ; Chapman, Louisa E. ; B Virus Working Group ; the B Virus Working Group</creatorcontrib><description>B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/344754</identifier><identifier>PMID: 12410479</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Acyclovir - adverse effects ; Acyclovir - analogs & derivatives ; Acyclovir - therapeutic use ; Animals ; Antiviral Agents - adverse effects ; Antiviral Agents - therapeutic use ; Antivirals ; Biological and medical sciences ; Cercopithecine herpesvirus 1 ; Chemoprevention - standards ; Drug Therapy - standards ; Encephalomyelitis - drug therapy ; Encephalomyelitis - etiology ; Encephalomyelitis - prevention & control ; Follow-Up Studies ; Health Planning Guidelines ; Herpesviridae Infections - drug therapy ; Herpesviridae Infections - physiopathology ; Herpesviridae Infections - prevention & control ; Herpesviridae Infections - transmission ; Herpesvirus 1, Cercopithecine - drug effects ; Herpesvirus 1, Cercopithecine - immunology ; Human viral diseases ; Humans ; Infections ; Infectious diseases ; Lesions ; Major Articles ; Medical sciences ; Preventive medicine ; Primates ; Primates - virology ; Symptoms ; Valine - adverse effects ; Valine - analogs & derivatives ; Valine - therapeutic use ; Viral diseases ; Viral diseases of the nervous system ; Viruses</subject><ispartof>Clinical infectious diseases, 2002-11, Vol.35 (10), p.1191-1203</ispartof><rights>Copyright 2002 The Infectious Diseases Society of America</rights><rights>2002 Infectious Diseases Society of America 2002</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c519t-f81616ba69196cc372ee452389062137b3b17f90516ae974981a46548fc064e03</citedby><cites>FETCH-LOGICAL-c519t-f81616ba69196cc372ee452389062137b3b17f90516ae974981a46548fc064e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4483293$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4483293$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14033257$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12410479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cohen, Jeffrey I.</creatorcontrib><creatorcontrib>Davenport, David S.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Deitchman, Scott</creatorcontrib><creatorcontrib>Hilliard, Julia K.</creatorcontrib><creatorcontrib>Chapman, Louisa E.</creatorcontrib><creatorcontrib>B Virus Working Group</creatorcontrib><creatorcontrib>the B Virus Working Group</creatorcontrib><title>Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1)</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis.</description><subject>Acyclovir - adverse effects</subject><subject>Acyclovir - analogs & derivatives</subject><subject>Acyclovir - therapeutic use</subject><subject>Animals</subject><subject>Antiviral Agents - adverse effects</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Antivirals</subject><subject>Biological and medical sciences</subject><subject>Cercopithecine herpesvirus 1</subject><subject>Chemoprevention - standards</subject><subject>Drug Therapy - standards</subject><subject>Encephalomyelitis - drug therapy</subject><subject>Encephalomyelitis - etiology</subject><subject>Encephalomyelitis - prevention & control</subject><subject>Follow-Up Studies</subject><subject>Health Planning Guidelines</subject><subject>Herpesviridae Infections - drug therapy</subject><subject>Herpesviridae Infections - physiopathology</subject><subject>Herpesviridae Infections - prevention & control</subject><subject>Herpesviridae Infections - transmission</subject><subject>Herpesvirus 1, Cercopithecine - drug effects</subject><subject>Herpesvirus 1, Cercopithecine - immunology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lesions</subject><subject>Major Articles</subject><subject>Medical sciences</subject><subject>Preventive medicine</subject><subject>Primates</subject><subject>Primates - virology</subject><subject>Symptoms</subject><subject>Valine - adverse effects</subject><subject>Valine - analogs & derivatives</subject><subject>Valine - therapeutic use</subject><subject>Viral diseases</subject><subject>Viral diseases of the nervous system</subject><subject>Viruses</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10ctu1DAUBmALUdEL8AQImUURXQR84vsSRh2mUsWlKgjNxvJ4TtSUSRzspGrfnrQZdVZd2db_6Vj6DyGvgX0EZtQnLoSW4hk5AMl1oaSF5-OdSVMIw80-Ocz5mjEAw-QLsg-lACa0PSDrCwyxabBd-76ObaZVTPRHwhts7980VtS3a3p5hcl3dw_p6W0X85CQ9pF-ob_rNGT6YYYpxK7urzDULdIFpg7zzUMGJy_JXuU3GV9tzyPya356OVsU59-_ns0-nxdBgu2LyoACtfLKglUhcF0iCllyY5kqgesVX4GuLJOgPFotrAEvlBSmCkwJZPyIvJ_mdin-GzD3rqlzwM3GtxiH7MDosQFudzCkmHPCynWpbny6c8DcfZ9u6nOEb7cTh1WD6x3bFjiC4y3wOfhNlXwb6rxzgnFeSj26d5OLQ_f0Z28mc537mB6VGDdYWj7GxRTXucfbx9inv05prqVb_Fm6n7O5Wn5bzt0F_w_h3517</recordid><startdate>20021115</startdate><enddate>20021115</enddate><creator>Cohen, Jeffrey I.</creator><creator>Davenport, David S.</creator><creator>Stewart, John A.</creator><creator>Deitchman, Scott</creator><creator>Hilliard, Julia K.</creator><creator>Chapman, Louisa E.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20021115</creationdate><title>Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1)</title><author>Cohen, Jeffrey I. ; Davenport, David S. ; Stewart, John A. ; Deitchman, Scott ; Hilliard, Julia K. ; Chapman, Louisa E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c519t-f81616ba69196cc372ee452389062137b3b17f90516ae974981a46548fc064e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acyclovir - adverse effects</topic><topic>Acyclovir - analogs & derivatives</topic><topic>Acyclovir - therapeutic use</topic><topic>Animals</topic><topic>Antiviral Agents - adverse effects</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Antivirals</topic><topic>Biological and medical sciences</topic><topic>Cercopithecine herpesvirus 1</topic><topic>Chemoprevention - standards</topic><topic>Drug Therapy - standards</topic><topic>Encephalomyelitis - drug therapy</topic><topic>Encephalomyelitis - etiology</topic><topic>Encephalomyelitis - prevention & control</topic><topic>Follow-Up Studies</topic><topic>Health Planning Guidelines</topic><topic>Herpesviridae Infections - drug therapy</topic><topic>Herpesviridae Infections - physiopathology</topic><topic>Herpesviridae Infections - prevention & control</topic><topic>Herpesviridae Infections - transmission</topic><topic>Herpesvirus 1, Cercopithecine - drug effects</topic><topic>Herpesvirus 1, Cercopithecine - immunology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lesions</topic><topic>Major Articles</topic><topic>Medical sciences</topic><topic>Preventive medicine</topic><topic>Primates</topic><topic>Primates - virology</topic><topic>Symptoms</topic><topic>Valine - adverse effects</topic><topic>Valine - analogs & derivatives</topic><topic>Valine - therapeutic use</topic><topic>Viral diseases</topic><topic>Viral diseases of the nervous system</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cohen, Jeffrey I.</creatorcontrib><creatorcontrib>Davenport, David S.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Deitchman, Scott</creatorcontrib><creatorcontrib>Hilliard, Julia K.</creatorcontrib><creatorcontrib>Chapman, Louisa E.</creatorcontrib><creatorcontrib>B Virus Working Group</creatorcontrib><creatorcontrib>the B Virus Working Group</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cohen, Jeffrey I.</au><au>Davenport, David S.</au><au>Stewart, John A.</au><au>Deitchman, Scott</au><au>Hilliard, Julia K.</au><au>Chapman, Louisa E.</au><aucorp>B Virus Working Group</aucorp><aucorp>the B Virus Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1)</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2002-11-15</date><risdate>2002</risdate><volume>35</volume><issue>10</issue><spage>1191</spage><epage>1203</epage><pages>1191-1203</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>12410479</pmid><doi>10.1086/344754</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2002-11, Vol.35 (10), p.1191-1203 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_18711839 |
| source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Acyclovir - adverse effects Acyclovir - analogs & derivatives Acyclovir - therapeutic use Animals Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Antivirals Biological and medical sciences Cercopithecine herpesvirus 1 Chemoprevention - standards Drug Therapy - standards Encephalomyelitis - drug therapy Encephalomyelitis - etiology Encephalomyelitis - prevention & control Follow-Up Studies Health Planning Guidelines Herpesviridae Infections - drug therapy Herpesviridae Infections - physiopathology Herpesviridae Infections - prevention & control Herpesviridae Infections - transmission Herpesvirus 1, Cercopithecine - drug effects Herpesvirus 1, Cercopithecine - immunology Human viral diseases Humans Infections Infectious diseases Lesions Major Articles Medical sciences Preventive medicine Primates Primates - virology Symptoms Valine - adverse effects Valine - analogs & derivatives Valine - therapeutic use Viral diseases Viral diseases of the nervous system Viruses |
| title | Recommendations for Prevention of and Therapy for Exposure to B Virus (Cercopithecine Herpesvirus 1) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A12%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20for%20Prevention%20of%20and%20Therapy%20for%20Exposure%20to%20B%20Virus%20(Cercopithecine%20Herpesvirus%201)&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Cohen,%20Jeffrey%20I.&rft.aucorp=B%20Virus%20Working%20Group&rft.date=2002-11-15&rft.volume=35&rft.issue=10&rft.spage=1191&rft.epage=1203&rft.pages=1191-1203&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/344754&rft_dat=%3Cjstor_proqu%3E4483293%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18711839&rft_id=info:pmid/12410479&rft_jstor_id=4483293&rft_oup_id=10.1086/344754&rfr_iscdi=true |